Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

cbdMD (YCBD) EBT Margin: 2016-2025

Historic EBT Margin for cbdMD (YCBD) over the last 9 years, with Sep 2025 value amounting to -14.40%.

  • cbdMD's EBT Margin fell 1105.00% to -14.40% in Q3 2025 from the same period last year, while for Sep 2025 it was -10.63%, marking a year-over-year increase of 794.00%. This contributed to the annual value of -10.63% for FY2025, which is 794.00% up from last year.
  • According to the latest figures from Q3 2025, cbdMD's EBT Margin is -14.40%, which was up 25.89% from -19.43% recorded in Q2 2025.
  • cbdMD's EBT Margin's 5-year high stood at 14.45% during Q2 2021, with a 5-year trough of -356.72% in Q2 2022.
  • In the last 3 years, cbdMD's EBT Margin had a median value of -18.54% in 2023 and averaged -40.20%.
  • As far as peak fluctuations go, cbdMD's EBT Margin slumped by 37,117bps in 2022, and later surged by 32,933bps in 2023.
  • Quarterly analysis of 5 years shows cbdMD's EBT Margin stood at -194.39% in 2021, then spiked by 13,100bps to -63.39% in 2022, then soared by 4,486bps to -18.54% in 2023, then skyrocketed by 1,883bps to 0.30% in 2024, then tumbled by 1,105bps to -14.40% in 2025.
  • Its EBT Margin was -14.40% in Q3 2025, compared to -19.43% in Q2 2025 and -10.12% in Q1 2025.